Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 6/2000

01-12-2000 | Non-peer-reviewed research

The International BRCA1 /2Carrier Cohort Study: Purpose, Rationale, and Study Design

Authors: D Goldgar, C Bonnardel, H Renard, O Yaqoubi

Published in: Breast Cancer Research | Issue 6/2000

Login to get access

Excerpt

International Agency for Research on Cancer, Lyon, France
D.
Goldgar, C. Bonnardel, H. Renard, O. Yaqoubi
 
…
Literature
1.
Breast Cancer Linkage Consortium : Cancer risks in BRCA2 Mutation Carriers. J Nat Cancer Inst. 1999, 91 (15): 1310-1316.
2.
Brunet JB, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, Weber BL, Lenoir GM, Lynch HT, Narod SA: Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes (Report). J Nat Cancer Inst. 1998, 90 (10): 761-766. 10.1093/jnci/90.10.761.CrossRef
3.
Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 1993, 52: 678-701.PubMedPubMedCentral
4.
5.
Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet,. 1994, 34: 692-695. 10.1016/S0140-6736(94)91578-4.CrossRef
6.
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Hedman MZ: Breast Cancer Linkage Consortium: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Human Genetics,. 1998, 62: 676-689. 10.1086/301749.CrossRef
7.
Goldgar DE, Rowe K, Lewis CM, McDonald M, Gholami K, Cannon-Albright L, Skolnick M: Genetic epidemiology of familial ovarian cancer in Utah. In: Ovarian Cancer - 3, edited by Sharp F, Mason P, Blackett T, and Berek J Chapman & Hall Medical. 1995, 13-21.
8.
Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H: Risk modifiers in carriers of BRCA1 mutations. Int J Cancer,. 1995, 64: 394-398.CrossRef
9.
Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BAJ, Cannon-Albright L., Larsson C, Goldgar DE, Narod SA: Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genetics,. 1996, 12: 309-311.CrossRef
10.
Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M: Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet,. 1999, 64 (5): 1371-1377. 10.1086/302366.CrossRef
Metadata
Title
The International BRCA1 /2Carrier Cohort Study: Purpose, Rationale, and Study Design
Authors
D Goldgar
C Bonnardel
H Renard
O Yaqoubi
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 6/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr93

Other articles of this Issue 6/2000

Breast Cancer Research 6/2000 Go to the issue

Commentary

Computer-assisted mammographic imaging

Research article

Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

Review

Molecular biology of breast cancer metastasis Genetic regulation of human breast carcinoma metastasis

Review

Molecular biology of breast cancer metastasis Clinical implications of experimental studies on metastatic inefficiency

Review

Molecular biology of breast cancer metastasis ‘Has it spread?’: Disarming one of the most terrifying questions

Review

Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits